Donoghue Forlines LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1702435 Boston, MA

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,223,070

+$1,009,187 QoQ

Shares Held

23,126

+17.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Donoghue Forlines LLC holds $5,355,712 across 3 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,691	$1,935,363
2	BMY	Bristol Myers Squibb Co	31,116	$1,792,903
3	PFE	Pfizer Inc	67,585	$1,627,446

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,223,070	23,126	+17.0%	Shares	Sole	2026-05-13
2025-03-31	$2,213,883	19,758	-50.5%	Shares	Sole	2025-05-12
2024-12-31	$3,690,550	39,954	+51.2%	Shares	Sole	2025-01-17
2024-09-30	$2,215,891	26,430	+31.7%	Shares	Sole	2024-11-13
2024-06-30	$1,377,208	20,073	+13.0%	Shares	Sole	2024-08-06
2024-03-31	$1,301,213	17,764	+22.2%	Shares	Sole	2024-05-07
2023-12-31	$1,177,480	14,535	-57.9%	Shares	Sole	2024-02-07
2023-09-30	$2,584,230	34,484	+21.7%	Shares	Sole	2023-11-06
2023-06-30	$2,183,624	28,333	+8.5%	Shares	Sole	2023-08-07
2023-03-31	$2,166,014	26,106	-17.3%	Shares	Sole	2023-05-08
2022-12-31	$2,709,511	31,561	+117.1%	Shares	Sole	2023-02-08
2022-09-30	$896,910	14,539	-46.8%	Shares	Sole	2022-11-07
2022-06-30	$1,690,318	27,347	-34.5%	Shares	Sole	2022-08-08
2022-03-31	$2,482,750	41,762	+29.7%	Shares	Sole	2022-05-16
2021-12-31	$2,337,243	32,189	-6.5%	Shares	Sole	2022-02-11
2021-09-30	$2,405,214	34,434	+75.8%	Shares	Sole	2021-11-15
2021-06-30	$1,348,898	19,589	+1.4%	Shares	Sole	2021-08-16
2021-03-31	$1,248,716	19,321	-49.4%	Shares	Sole	2021-05-14
2020-12-31	$2,224,017	38,174	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.